DaVita Inc. logo

DaVita Inc. (DVA)

Market Closed
24 Feb, 20:00
NYSE NYSE
$
150. 91
-0.37
-0.24%
Pre Market
$
152. 00
+1.09 +0.72%
10.08B Market Cap
16.41 P/E Ratio
- Div Yield
590,738 Volume
7.83 Eps
$ 151.28
Previous Close
Day Range
146.67 151.39
Year Range
101 157.12
Want to track DVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DVA earnings report is expected in 75 days (11 May 2026)
4 Stocks Trading Near 52-Week High With More Upside Potential

4 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.

Zacks | 1 year ago
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know

DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know

Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Is DaVita (DVA) a Great Value Stock Right Now?

Is DaVita (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Are Medical Stocks Lagging DaVita (DVA) This Year?

Are Medical Stocks Lagging DaVita (DVA) This Year?

Here is how DaVita HealthCare (DVA) and Avadel (AVDL) have performed compared to their sector so far this year.

Zacks | 1 year ago
DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up

DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up

DaVita's (DVA) robust segmental revenues drive its second-quarter performance.

Zacks | 1 year ago
DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates

DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates

DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago.

Zacks | 1 year ago
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings

Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings

Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.

Zacks | 1 year ago
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.

Zacks | 1 year ago
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025

2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025

As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.

Finbold | 1 year ago
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.

Zacks | 1 year ago
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts

DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts

DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.

Zacks | 1 year ago
Loading...
Load More